{{Rsnum
|rsid=2230641
|Gene=CCNH
|Chromosome=5
|position=87399457
|Orientation=minus
|GMAF=0.1382
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CCNH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 26.6 | 67.2
| HCB | 2.2 | 11.1 | 86.7
| JPT | 0.0 | 18.2 | 81.8
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 11.1 | 86.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=16465622
|Title=Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
|OA=1
}}

{{PMID Auto
|PMID=18708406
|Title=Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China.
|OA=1
}}

{{PMID Auto
|PMID=18711149
|Title=Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.
|OA=1
}}

{{PMID Auto
|PMID=18854777
|Title=Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.
|OA=1
}}

{{PMID Auto
|PMID=19074885
|Title=Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
}}

{{PMID Auto
|PMID=19270000
|Title=Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.
|OA=1
}}

{{PMID Auto
|PMID=20141440
|Title=Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
|OA=1
}}{{GET Evidence
|gene=CCNH
|aa_change=Val270Ala
|aa_change_short=V270A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2230641
|overall_frequency_n=1863
|overall_frequency_d=10758
|overall_frequency=0.173173
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.997
|nblosum100=2
|autoscore=1
|webscore=N
}}
{{PMID Auto
|PMID=24351404
|Title=Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study
}}